Brief: Brooklyn Immunotherapeutics Posts Quarterly Loss Per Share Of $1.70

Ernexa Therapeutics

09/11/2021 23:34

Nov 9 (Reuters) - Brooklyn Immunotherapeutics Inc  BTX.O :
    * BROOKLYN IMMUNOTHERAPEUTICS ANNOUNCES THIRD QUARTER 2021
FINANCIAL RESULTS
    * BROOKLYN IMMUNOTHERAPEUTICS INC - AS OF SEPTEMBER 30,
2021,
BROOKLYN HAD APPROXIMATELY $24.4 MILLION IN CASH
    * BROOKLYN IMMUNOTHERAPEUTICS INC QTRLY LOSS PER SHARE $1.70

Source text for Eikon:  ID:nGNX2zVjq1 
Further company coverage:  BTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))